Health Canada is warning that the cancer drug Revlimid may be linked to new cancers developing in people who take it.
New cancer tumours have been reported in a small number of people who have taken the drug.
The warning does not include those using the drug who are being treated for anemia.
Health Canada and the drug manufacturer Celgene are updating the label information to make note of the concern.
New cancer drug may be linked to developing new tumours
680News staff
Gas Prices
680News Android App
Weather Guarantee
Advertiser Directory
Comments
Editor's note: Comments which include offensive or inappropriate language will be deleted. Healthy debate is encouraged but we will not permit any personal attacks. View our comment policy here.